Young Rc
About
In The Last Decade
Young Rc
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Oncology 560
- Pathology and Forensic Medicine 253
- Reproductive Medicine 195
- Pulmonary and Respiratory Medicine 193
- Surgery 185
Countries citing papers authored by Young Rc
This map shows the geographic impact of Young Rc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Rc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Rc more than expected).
Fields of papers citing papers by Young Rc
This network shows the impact of papers produced by Young Rc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Rc. The network helps show where Young Rc may publish in the future.
Co-authorship network of co-authors of Young Rc
This figure shows the co-authorship network connecting the top 25 collaborators of Young Rc. A scholar is included among the top collaborators of Young Rc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young Rc. Young Rc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Management of early ovarian cancer. | 21 |
| 2 | Blood gas/electrolyte analysis during patient evacuation and in the prehospital environment. | 0 |
| 3 | Inositol phospholipid-dependent cellular signalling: opportunities for drug discovery. | 3 |
| 4 | Modulation of drug resistance in human ovarian cancer: experimental results and clinical applications. | 2 |
| 5 | Deep venous thrombosis during therapy for Hodgkin's disease. | 38 |
| 6 | 38 | |
| 7 | Ovarian cancer treatment: progress or paralysis? | 12 |
| 8 | MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity. | 16 |
| 9 | Plasma desipramine levels after single dosage and at steady state in outpatients. | 2 |
| 10 | Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin. | 28 |
| 11 | Ovarian carcinoma: an optimistic epilogue. | 10 |
| 12 | Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule. | 34 |
| 13 | Sequential staging in non-Hodgkin's lymphoma. | 34 |
| 14 | Lung function abnormalities occurring in sickle cell hemoglobinopathies: a preliminary report. | 10 |
| 15 | Chemotherapy of ovarian cancer: past and present. | 70 |
| 16 | Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinoma. | 8 |
| 17 | A new experimental model of hypokinesia. | 11 |
| 18 | High-dose intermittent intravenous infusion of procarbazine (NSC-77213). | 7 |
| 19 | New concepts of delivery of health care to the patient with lung disease. | 1 |
| 20 | Intensive chemotherapy for Hodgkin's disease: long-term complications. | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.